Evidence map›Paper›PMID 20535453›Full record

ArticlePsychopharmacology2010

Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Amir H Rezvani, Susan Slade, Cori Wells, Ann Petro, Lawrence Lumeng, Ting-Kai Li, Yingxian Xiao, Milton L Brown, Mikell A Paige, Brian E McDowell and 3 more

Abstract read
In one paragraph

Article in Psychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Progress in neuro-psychopharmacology & biological psychiatry · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Amir H RezvaniDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box 104790, Durham, NC 27710, USA. azadi@duke.edu
Susan Slade
Cori Wells
Ann Petro
Lawrence Lumeng
Ting-Kai Li
Yingxian Xiao
Milton L Brown
Mikell A Paige
Brian E McDowell
Jed E Rose
Kenneth J Kellar
Edward D Levin
Georgetown University · USDuke Medical Center · USDuke University · USIndiana University – Purdue University Indianapolis · US

Funding

Recruitment CoreP50DA027840 · NIDA · DUKE UNIVERSITY · PI DAVIS, JAMES M · 2010 to 2019
$14.9M
Synthesis and Optimization of Selective alpha4beta2 Neuronal nAChR DesensitizersU19DA027990 · NIDA · GEORGETOWN UNIVERSITY · PI LEVIN, EDWARD D · 2010 to 2014
$4.3M
NIDA NIH HHS P50 DA027840NIDA NIH HHS U19 DA027990
6 · The paper itself

Abstract

rationaleManipulations of nicotinic cholinergic receptors have been shown to influence both alcohol and nicotine intake. Sazetidine-A [6-(5(((S)-azetidine-2-yl)methoxy)pyridine-3-yl)hex-5-yn-1-ol] is a novel compound that potently and selectively desensitizes alpha4beta2 nicotinic receptors with only modest receptor activation.

objectivesThe goal of the present study was to examine the effects of sazetidine-A on alcohol and nicotine self-administration in alcohol-preferring (P) rats.

methodsP rats were given the choice of water or alcohol. Once stable baselines were established, the acute (0, 0.1, 0.3, 1, and 3 mg/kg, s.c.) and chronic (3 mg/kg for 10 days) effects of sazetidine-A on alcohol intake were assessed. Naltrexone (2.5 mg/kg) served as a positive control. The effect of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on saccharin (0.2%) preference was also assessed. In addition, the acute effects of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on alcohol intake after alcohol deprivation were evaluated. In another experiment, the effects of sazetidine-A (0, 1, or 3 mg/kg) on i.v. nicotine self-administration in P and NP rats were assessed.

resultsSazetidine-A caused a dose-dependent reduction in alcohol intake. Chronic sazetidine-A also effectively reduced alcohol intake until the seventh day of treatment, when partial tolerance appeared to develop. In the post-deprivation study, sazetidine-A significantly reduced alcohol intake and preference. Sazetidine-A at 3 mg/kg significantly reduced nicotine self-administration in both lines.

conclusionsSazetidine-A significantly reduced alcohol and nicotine intake in P rats that self-administer higher levels of both drugs. Sazetidine-A may hold promise for the treatment of alcohol and nicotine addiction.

Indexed as

AnimalsAzetidinesDose-Response Relationship, DrugDrug Administration ScheduleEthanolMaleNaltrexoneNarcotic AntagonistsNicotineNicotinic AgonistsPyridinesRatsReceptors, NicotinicRewardSaccharinSelf AdministrationAzetidinesEthanolNaltrexoneNarcotic AntagonistsNicotineNicotinic Agonistsnicotinic receptor alpha4beta2PyridinesReceptors, NicotinicSaccharinsazetidine-A

Identifiers

PMID20535453
PMCPMC3695635
OpenAlexW1985530197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.